Experimental Therapies for Ebola Virus Disease: What Have We Learned?
about
An update on ocular complications of Ebola virus disease.Clinician-initiated research on treating the host response to pandemic influenza.West Africa 2013 Ebola: From Virus Outbreak to Humanitarian Crisis.Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
P2860
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
@ast
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
@en
type
label
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
@ast
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
@en
prefLabel
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
@ast
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
@en
P2860
P356
P1476
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
@en
P2093
Daniel G Bausch
Martin Friede
P2860
P304
P356
10.1093/INFDIS/JIW496
P407
P577
2017-01-01T00:00:00Z